178 related articles for article (PubMed ID: 38029705)
1. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
2. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
Pandey A; Pandey P; Ghasabeh MA; Zarghampour M; Khoshpouri P; Ameli S; Luo Y; Kamel IR
Radiology; 2018 Dec; 289(3):843-853. PubMed ID: 30129899
[TBL] [Abstract][Full Text] [Related]
3. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
Pandey A; Pandey P; Aliyari Ghasabeh M; Najmi Varzaneh F; Shao N; Khoshpouri P; Zarghampour M; Fouladi DF; Liddell R; Kamel IR
Radiology; 2018 Jul; 288(1):109-117. PubMed ID: 29584595
[TBL] [Abstract][Full Text] [Related]
4. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
[TBL] [Abstract][Full Text] [Related]
5. A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma.
Maßmann M; Treckmann J; Markus P; Schumacher B; Albers D; Ting S; Mende B; Roehrle J; Virchow I; Rosery V; Laue K; Zaun G; Kostbade K; Pogorzelski M; Schmid KW; Baba H; Siveke JT; Paul A; Schildhaus HU; Schuler M; Wiesweg M; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5085-5094. PubMed ID: 36334155
[TBL] [Abstract][Full Text] [Related]
6. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study.
Liguori C; Copparoni C; Felicetti C; Pecci F; Lupi A; Pinterpe G; Berardi R; Giampieri R
Curr Oncol; 2023 Jan; 30(1):1032-1045. PubMed ID: 36661728
[TBL] [Abstract][Full Text] [Related]
9. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
10. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.
Abou-Alfa GK; Bibeau K; Schultz N; Yaqubie A; Millang B; Ren H; Féliz L
Target Oncol; 2022 Sep; 17(5):517-527. PubMed ID: 36114955
[TBL] [Abstract][Full Text] [Related]
11. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma.
Franssen S; Soares KC; Jolissaint JS; Tsilimigras DI; Buettner S; Alexandrescu S; Marques H; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Margonis GA; Weiss MJ; Bauer TW; Shen F; Poultsides GA; Marsh JW; Cercek A; Kemeny N; Kingham TP; D'Angelica M; Pawlik TM; Jarnagin WR; Koerkamp BG
JAMA Surg; 2022 Jul; 157(7):590-596. PubMed ID: 35544131
[TBL] [Abstract][Full Text] [Related]
14. A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score.
Jiang W; Zeng ZC; Tang ZY; Fan J; Sun HC; Zhou J; Zeng MS; Zhang BH; Ji Y; Chen YX
Ann Oncol; 2011 Jul; 22(7):1644-1652. PubMed ID: 21212156
[TBL] [Abstract][Full Text] [Related]
15. The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study.
Cai QY; Yang P; Yang XL; Zhang XH; Guo LP; Lu XY; Huo L; Ma HB; Wang XD; Zhou HB; Wu L; Jia NY
Cancer; 2023 Oct; 129(19):2999-3009. PubMed ID: 37449788
[TBL] [Abstract][Full Text] [Related]
16. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
17. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
[TBL] [Abstract][Full Text] [Related]
18. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Yang Z; Zhang D; Sima X; Fu Y; Zeng H; Hu Z; Hou J; Pan Y; Zhang Y; Zhou Z; Chen M; Hu D
Int Immunopharmacol; 2023 Feb; 115():109687. PubMed ID: 36628893
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
